Your browser doesn't support javascript.
loading
Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells.
Ravanidis, Stylianos; Bogie, Jeroen F J; Donders, Raf; Deans, Robert; Hendriks, Jerome J A; Stinissen, Piet; Pinxteren, Jef; Mays, Robert W; Hellings, Niels.
Afiliação
  • Ravanidis S; Biomedical Research Institute/Transnational University Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
  • Bogie JFJ; Biomedical Research Institute/Transnational University Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
  • Donders R; Biomedical Research Institute/Transnational University Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
  • Deans R; Department of Regenerative Medicine, Athersys Inc., Cleveland, OH, USA.
  • Hendriks JJA; Biomedical Research Institute/Transnational University Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
  • Stinissen P; Biomedical Research Institute/Transnational University Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
  • Pinxteren J; ReGenesys BVBA, Leuven, Belgium.
  • Mays RW; Department of Regenerative Medicine, Athersys Inc., Cleveland, OH, USA.
  • Hellings N; Biomedical Research Institute/Transnational University Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium.
Stem Cells Int ; 2017: 2353240, 2017.
Article em En | MEDLINE | ID: mdl-28785285
Macrophages and microglia are key effector cells in immune-mediated neuroinflammatory disorders. Driving myeloid cells towards an anti-inflammatory, tissue repair-promoting phenotype is considered a promising strategy to halt neuroinflammation and promote central nervous system (CNS) repair. In this study, we defined the impact of multipotent adult progenitor cells (MAPC), a stem cell population sharing common mesodermal origin with mesenchymal stem cells (MSCs), on the phenotype of macrophages and the reciprocal interactions between these two cell types. We show that MAPC suppress the secretion of tumor necrosis factor alpha (TNF-α) by inflammatory macrophages partially through a cyclooxygenase 2- (COX-2-) dependent mechanism. In turn, we demonstrate that inflammatory macrophages trigger the immunomodulatory properties of MAPC, including an increased expression of immunomodulatory mediators (e.g., inducible nitric oxide synthase (iNOS) and COX-2), chemokines, and chemokine receptors. Macrophage-primed MAPC secrete soluble factors that suppress TNF-α release by macrophages. Moreover, the MAPC secretome suppresses the antigen-specific proliferation of autoreactive T cells and the T cell stimulatory capacity of macrophages. Finally, MAPC increase their motility towards secreted factors of activated macrophages. Collectively, these in vitro findings reveal intimate reciprocal interactions between MAPC and inflammatory macrophages, which are of importance in the design of MAPC-based therapeutic strategies for neuroinflammatory disorders in which myeloid cells play a crucial role.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article